Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm doing quite a bit of shopping and have found the Fireman's Contractor's ... taking a good look there!
Long as we keep Pauly Pierce on his feet we are GREAT !!!!!!
So many choices here Poemstone.. I love it!
Poemstone., great choice of companies here!! ... so glad I stopped by... always a great sign when you show up on a board!!
Dii Dii
Wow.. awesome company here!!
http://www.cannabis-med.org/studies/study.php Clinical studies
and case reports.
MJNA
Roger that PoemStone.. every day closer is to the announcements will mean more lives saved...
Extremely encouraging and telling update to the side BSW ~
MMTC
I bet they do Zo, because management likes the social media stream, and I'm sure they want to see what investors and potential investors think about their product and their management style.
The clinical studies and case reports:
http://www.cannabis-med.org/studies/study.php
MJNA
Taking the customer base overnight to over a million, in one state alone... simply unprecedented territory.... MJNA
Great post ! Thanks Gutter92!
MMTC - Very exciting with all the insider buys registered this week!!
http://www.thestreet.com/video/11662209/the-bullish-case-for-legal-cannabis.html
Same video without the advertisement intro:
There are so few hours left to have a foothold in this
once in a lifetime opportunity. Being on the ground floor of
MNJA (with the huge look pharma and tobacco are giving us)
This could be the next GW* Pharmaceutical ... @ 70.00 a share.
Big Pharam all over MJNA Magic Mike ~
check out all the indicators at Barchart!!
http://www.barchart.com/opinions/stocks/MJNA
http://www.thestreet.com/video/11662209/the-bullish-case-for-legal-cannabis.html
Same video without the advertisement intro:
http://www.thestreet.com/video/11662209/the-bullish-case-for-legal-cannabis.html
Same video without the advertisement intro:
Wow!!! And it just got to the shelves on Monday I think!
MJNA
I'm thinking it may have sold out - here in Mass ; )
MJNA
Last night I tried to buy Newsweek at my local Walmart they did not have it... I'll be checking local CVS today ~
MJNA
lol !!! Glad you like it BR ; )
MJNA fun ride !!!!
Morning all MJNA ers ~ To those with L2, does that open at .15 look like it will stick?
Sell orders set for $4.20 ;)
Market is unprecedented. MMTC Mit 1000 is the doorway to the future of food safety. Keep in mind Obama's Food Safety Modernization Act.. This technology has been certified by only the most credible agency that offers the certs. www.aoac.org/
I am checking daily for the cert to show up... would like to have a heads up ;)
Hi JP, Let's hope Peter Lewis and his $$$$ are on top of this
and will send in the cavalry to fight the Feds on behalf
of Harborside.
Peter Lewis is the founder of Progressive Insurance and is
donating millions and millions for the legalization of
Marijuana Legalization.
http://www.forbes.com/sites/clareoconnor/2012/04/20/high-roller-how-billionaire-peter-lewis-is-bankrolling-marijuana-legalization/
As was stated on the 60 minutes episode one week ago tonite,, the spokesperson for the Fed said "they hear what the people want., they do not want the government spending money going after dispensaries in MM approved states." Also per the spokesperson for the Fed... "we do not have enough manpower to go after every dispenser y in every state"...
MJNA get in NOW ;)
How Big Is The Marijuana Market?
Please open this link for charts showing potential: http://www.cnbc.com/id/36179677
Published: Tuesday, 20 Apr 2010 | 12:04 AM ET Text Size
By: Ariel Nelson
Director of Market Data & Content Services
Put arguments for and against legalization aside for a moment. If people could use marijuana—without fear of legal consequence—just how much would get used? More to the point, how much money is at stake?
Getty Images
A variety of businesses and tax-deprived governments would love to know the answer. Unfortunately, there isn’t a simple one. By its taboo nature, marijuana consumption and demand is not well-measured.
Economists, reformists, law enforcement authorities and the pro-marijuana lobby, however, have come up with a variety of estimates. Put them all together and you get a range of $10 billion to over $120 billion a year. Such a wide spread is hardly a solid answer.
But some calculations may be better than others. All estimates begin with some key assumptions on the basic economic theory of supply and demand, thus laying the foundation for the size of the pot market.
Demand-Based Models: How Much Do People Consume?
Demand-based models use consumption volumes and price to estimate the size of a total market. Here, the tricky part is coming up with exact figures on how much pot is consumed and how much it costs. Opinions differ.
The US Department of Health & Human Services' Substance Abuse & Mental Health Administration conducts a National Survey on Drug Use and Health. This survey, among others like it, states that roughly 10 percent of the population above the age of 12 has used marijuana in the past year, while 6 percent has used it in any given month. Of all monthly users, 15 percent use marijuana on a daily basis. By comparison, 52 percent of Americans above the age of 12 have had an alcoholic beverage and 28 percent have used tobacco in any given month.
While tobacco use has drifted downward from over 30 percent of the population per month, the marijuana percentages have been roughly consistent for at least the past ten years, according to H&HS data, and have varied by less than 1 percent over a two-decade period. Alcohol consumption has also been relatively constant, hovering around 51 percent.
On price and volume, various reports and studies conclude a typical marijuana cigarette, or joint, contains between 0.5 - 1.0 grams of the drug. The price of a gram can vary from $5-$20, or even more depending on potency and origin. Among others, "High Times" magazine conducts a monthly survey of its readers to aggregate prices from around the country. See its current survey results here.
Based on this data, most demand-based studies put the market at $10-$40 billion. If a sensitivity analysis is applied to consumption and price variables (that is, testing different combinations of price and use), the market can reach as high as $100 billion (see chart). It all depends on what you believe, given the number of variables involved. Are more consumers smoking more frequently and at higher prices or less frequently at lower prices? The answer is probably somewhere in the middle.
Proponents of this approach include Harvard economist Jeffrey Miron, perhaps the foremost independent authority on the economics of drug use, and the lobby group National Organization for the Reform of Marijuana Laws, NORML. (See the analysis of NORML's California branch.) Miron conservatively sizes the market at about $14 billion and in his February 2010 paper on "The Budgetary Implications of Drug Prohibition" states that legalization of marijuana could yield over $20 billion in tax revenues and enforcement cost savings.
Critics of these estimates argue that these surveys, because they are administered by the government, underreport the number of users. The frequency of usage and price estimates vary as well.
Supply-Side Models: How Much Pot is Farmed?
The alternative approach is to look at the supply side of the equation. Proponents of this methodology look at seizures by the US Drug Enforcement Administration and US Customs and Border Protection as a measure of how much cannabis is in the system and then extrapolate out based on assumptions for what percent of the market the captured material represents.
Unlike the steady levels of consumption, the levels of supply, seizures and eradications keep growing. According to the DEA’s National Drug Intelligence Center, over 7 million plants were eradicated in 2007, up 120 percent from 2004. The DEA seized 660,969 kg (1.5 million pounds) of marijuana in 2008, up 149 percent from 2005.
In his 2006 study, "Marijuana Production in the United States", Dr. John Gettman, a marijuana reform activist and professor at George Mason University, used data from the DEA and other sources in estimating that the average, annual domestic marijuana crop totaled some 65 million plants at a weight of 22 million pounds (10,000 metric tons). In addition, he calculated that another 50 percent was harvested in neighboring Mexico and Canada.
Based on average yields for these plants of ~7 oz per outdoor plant and ~3.5 oz per indoor plant, assumptions on the total crop size, and using the aforementioned price ranges per ounce or per joint as well as consumption rates, the market value swells to up to $120 billion.
Critics of this approach argue that the DEA numbers are inflated because the federal government has an incentive to demonstrate it is winning the war on drugs. Further, they say, the actual measure of weight is inflated because some of the confiscated material is finished product while a large amount consists of entire plants (not the flowers and leaves typically used) along with the root structure that is weighed down by soil.
Harvard's Miron tells CNBC, "some people have produced estimates of the size of the marijuana market that are literally 20 times my estimates... there are aspects of the methodology that have been used to produce these numbers that are substantially higher than mine that I find problematic. So, I think that the smaller number is much more likely, it could well be that I’m wrong, and that it's $15-17 billion, but the $200 billion is hard to believe."
Comparisons: Alcohol or Tobacco?
A third way to look at the market is by comparing it to other vices that are already legal.
According to a November 2009 Standard & Poor's industry report, the tobacco and alcohol industries generated $263 billion combined in 2008. Alcohol represented $188 billion of the total, with $99 billion in beer, $61 billion in spirits and $27 billion in wine. Tobacco generated $75 billion, including $71 billion in cigarette sales.
This gut-check approach asks, can marijuana be bigger than cigarettes or beer (if it were legal)?
Another way to think about this is to ask yourself, if a typical smoker consumes 1 pack of cigarettes per day and spends $7-8 per pack, what would a marijuana user need to smoke for the market to be as big? (Not to suggest that drinkers or smokers would necessarily become marijuana users).
According to the H&HS data, there are nearly 5 to 1 as many smokers as there are pot users. For the pot market to be as big as tobacco, the average user would need to spend $35-40 per day, or smoke 2-4 joints per day. That number implies that perhaps the marijuana market would need to be smaller.
Reasonable Range? $35-45 Billion
If you believe prices are higher and/or users will partake more then assumed in the data then you will likely fall on the right side of the scale. If, however, you believe consumption will remain low and legalization will actually bring prices down, then the marijuana market will be smaller. After looking at all three approaches above, the answer likely falls somewhere in the middle, between $35 and $45 billion.
Tobacco and alcohol sales generate over $17 billion in federal tax revenue. States tax tobacco and alcohol and benefit as well. Given the current economic environment and the deficits states are facing, it is understandable why legalization is a topic of discussion. Assuming comparable taxes to tobacco of 40-50% (excise and sales tax), a $40 billion marijuana market would yield $16-20 billion in taxes.
© 2012 CNBC.com
PrintEmail
Roger that Jack, MJNA is in unprecedented territory here in the states.. Potential market in the billions of dollars.
http://www.cnbc.com/id/36179677
Owning MJNA is like being on the ground floor when APP* began...
Of the 20 stocks listed on marijuanastocks.com all but one
are located in the US and are traded in the OTC tiers.
That one stock is trading on the AIM of the London Exchange and is 70.00 a share and sells one pharmaceutical.
You can bet big pharma is all over this industry in a frenzy this week and next ~
MJNA ;) uncharted territory !!
Huge!! MJNA is like being on the doorstep of Apple!!
"There are 4 worldwide pharmaceutical companies that have synthetic CBD extracts - and they do a business in excess of $1 billion annually. MJNA’s products are organically grown - not synthetic."
"As products emerge, the Company (MJNA) plans to contract and partner with other pharmaceutical companies on clinical trials for efficacy of their formulations."
MJNA ~ has all it needs to be the US version of *WP from UK is 70.50 pps with 133M OS and 9.4B MC
The potential pps for MJNA is beyond my comprehension at this point..
http://data.cnbc.com/quotes/GWP-GB
From their website:
GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications
GW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.
http://www.gwpharm.com/faqs.aspx
The potential pps for this stock is unprecedented... this could easily see the similar pps of it's peers already legalized in Europe / UK well into the 65.00 range... we are on the doorstep of uncharted territory here in the states....
Go MJNA !!
;)
Hi LST, GWP from UK is 70.50 pps with 133M OS and 9.4B MC
The potential pps for MJNA is beyond my comprehension at this point..
http://data.cnbc.com/quotes/GWP-GB
From their website:
GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications
GW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.
http://www.gwpharm.com/faqs.aspx
If the rumor were true we would all be very rich, but it is at least a window into the potential of what we have here....
best of luck to all ~ MJNA !!
Hello MJNA !!
Best of luck to all here !!
Excellent PR MMTC !! It looks like much more than an announcement of an event they are attending., but more of an 'educational PR' for new investors... they got their money's worth out of this PR I'd say!!
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that it will attend the 7th Annual International Conference for Food Safety and Quality on November 13-14, 2012 in Chicago, Illinois. We will have the privilege of making a brief presentation of our Rapid Microbial Identification System, the MIT 1000, to food safety professionals throughout the government, academia and food supply industries.
Each year, the Food Safety Institute of America hosts a conference which provides attendees with information on current and emerging food safety issues, the latest science, innovative solutions to new and recurring problems, and the opportunity to network with thousands of food safety professionals from around the globe. "This conference will be another excellent opportunity to bring the MIT 1000 to the direct attention of the food safety community and those professionals who will embrace the value of our technology and its diagnostic capabilities," stated Jeff Nunez, MIT's Chairman and CEO. "As we expand on our marketing strategy and increase attention on the MIT brand, we anticipate that our product will continue to generate a great deal of interest."
The MIT 1000 is a stand-alone, optically-based, software driven system that can detect pathogenic bacteria and complete an identifying test in less than five (5) minutes for pennies per test. According to MIT's Chief Scientist, David Haavig, PhD, "In the U.S. alone, around 76 million cases of food-borne illnesses, resulting in 325,000 hospitalizations and 5,000 deaths, are estimated to occur each year. The leading cause of these illnesses and deaths are three main strains of bacteria: E. coli, Salmonella, and Listeria. Rapid identification of these disease-causing pathogens in food is critical to the health and safety of all consumers."
The AOAC Research Institute (AOAC RI) awarded the Company in June 2009, Performance Tested Methods SM (PTM) certification for the rapid identification of Listeria. The AOAC RI provides an independent third party evaluation and expert reviews of methods and will award PTM certification to methods that demonstrate performance levels equivalent or better than other certified bacteria identifying methods. The MIT System underwent hundreds of individual tests, including ruggedness and accuracy, to earn AOAC RI's certification for the identification of Listeria.
About: AOAC International and AOAC Research Institute
AOAC INTERNATIONAL is a globally recognized, independent, not-for-profit association founded in 1884. To attain its vision of "worldwide confidence in analytical results," AOAC serves analytical science communities by providing the tools and processes necessary to develop voluntary consensus standards or technical standards through stakeholder consensus and working groups in which the fit-for-purpose and method performance criteria are established and fully documented. The AOAC Research Institute is a subsidiary of AOAC INTERNATIONAL and maintains an up-to-the minute list of certified Performance Tested Methods which have been independently tested, rigorously evaluated and thoroughly reviewed by the AOAC Research Institute and its expert reviewers.
About: Micro Imaging Technology, Inc.
MIT is a California-based public company that has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. The MIT 1000 identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any other conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6 percent.
This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission, reference MMTC: www.sec.gov.
Yes., it certainly does Kalstone!!! MMTC ~ just no gray area here... product., distribution, certification en route, financial backing., insiders own most of the shares... and only 15 months ago, Obamba signed the 'Food Modernization Act'.. the first change since 1938 !! did I forget something? ...
http://articles.cnn.com/2011-01-04/politics/obama.food.safety_1_food-safety-fda-power-commissioner-margaret-hamburg?_s=PM:POLITICS
OH !!! OSIS is manufacturing the MIT 1000 - for the next 5 years!!!
Agreed KyMike., we will move on air... over 80% of MMTC float owned by insiders.... crazy!! And the inside buying continues!!
p.s. I have looked back 24 months.. no inside sells ~~~
I wonder if MMTC will have "in house financing" like Toshiba?
Sure BSW! Why not !! BOD of MMTC has shown public how easy the MIT 1000 is to use and understand... this video on Youtube is bringing us one step closer to lift off.
Nice video - love the product even more now !! GO MMTC !!
lol!! Thanks Touch !!! And again with the insider buying !!!!!
SOMETHING'S HAPPENING HERE !!!!!!!!! GO MMTC !!!
MEGA INSIDE BUYING + BOD + OSIS + CERTS ON WAY = MONSTER MMTC